A. Matsunaga

发表

Evaluation of the Time-Dependent Changes and the Vulnerability of Carotid Plaques Using Contrast-Enhanced Carotid Ultrasonography.

H. Abe, Tooru Inoue, Hirofumi Shimada, 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia

K. Saku, M. Nagashima, A. Matsunaga, 2020, Journal of atherosclerosis and thrombosis.

Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.

J. Sasaki, A. Matsunaga, N. Sakuma, 2014, Journal of atherosclerosis and thrombosis.

A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.

N. Tomita, N. Komai, N. Kashihara, 2011, Journal of atherosclerosis and thrombosis.

Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity

Y. Fujioka, A. Matsunaga, K. Nakabayashi, 2007, Clinical and Experimental Nephrology.

Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

S. Oikawa, A. Matsunaga, Takao Saito, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Associations among plasma lipoprotein subfractions as characterized by analytical capillary isotachophoresis, apolipoprotein E phenotype, Alzheimer disease, and mild cognitive impairment.

B. Zhang, K. Saku, Tatsuo Yamada, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency.

J. Sasaki, J. Kobayashi, N. Morisaki, 2000, Clinica chimica acta; international journal of clinical chemistry.

Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy

T. Saruta, J. Sasaki, S. Oikawa, 1999, Nephron.

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.

T. Kita, J. Sasaki, K. Arakawa, 1999, Kidney international.

A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.

J. Sasaki, K. Uchida, S. Oikawa, 1999, Kidney international.

Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.

J. Sasaki, H. Jingami, S. Oikawa, 1997, Journal of the American Society of Nephrology : JASN.

Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis.

Y. Ito, J. Sasaki, K. Arakawa, 1996, Biochimica et biophysica acta.

Population frequency of apolipoprotein E5 (Glu3→Lys) and E7 (Glu244→Lys, Glu245→Lys) variants in western Japana

J. Sasaki, K. Arakawa, A. Matsunaga, 1995, Clinical genetics.

Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.

J. Sasaki, K. Arakawa, A. Matsunaga, 1992, Biochimica et biophysica acta.

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter‐Defibrillator

S. Miura, K. Saku, K. Kumagai, 2010 .

Histochemical Characteristics of Soleus Muscle in Angiotensin-Converting Enzyme Gene Knockout Mice

S. Jimi, K. Saku, B. Zhang, 2005, Hypertension Research.

[The application of fluorescence in situ hybridization to the peripheral-blood preparations].

I. Miura, A. Matsunaga, Y. Takamatsu, 2011, Fukuoka igaku zasshi = Hukuoka acta medica.

In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.

J. Sasaki, K. Arakawa, S. Horiuchi, 2000, Atherosclerosis.

Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation.

S. Imaizumi, K. Saku, M. Ogawa, 2016, Journal of cardiology.

Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004

Yi-Wei Tang, H. Ishikura, A. Matsunaga, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Antioxidative Effects of Fluvastatin on Superoxide Anion Activated by Angiotensin II in Human Aortic Smooth Muscle Cells

J. Sasaki, K. Arakawa, A. Matsunaga, 2002, Cardiovascular Drugs and Therapy.

Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease.

S. Miura, K. Saku, A. Matsunaga, 2015, Journal of cardiology.

A cysteine-containing truncated apo A-I variant associated with HDL deficiency.

J. Sasaki, K. Arakawa, J. Albers, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency.

Wei Huang, J. Sasaki, K. Arakawa, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Apolipoprotein E epsilon 4.

S. Sakoda, J. Sasaki, M. Osame, 1994, Neurology.

Comparison of Two Homogeneous LDL-Cholesterol Assays Using Fresh Hypertriglyceridemic Serum and Quantitative Ultracentrifugation Fractions

K. Saku, A. Matsunaga, Bo Zhang, 2019, Journal of atherosclerosis and thrombosis.

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study

Y. Uehara, K. Saku, M. Ogawa, 2009, Journal of Lipid Research.

Apolipoprotein E-related glomerular disorders.

M. Fukunaga, K. Nagahama, A. Matsunaga, 2019, Kidney international.

First reported case of hemoglobin lansing in Asia detected by false low oxygen saturation on pulse oximetry

J. Uchino, A. Matsunaga, K. Ishitsuka, 2012, International Journal of Hematology.

Left ventricular pseudoaneurysm following acute myocardial infarction.

K. Saku, A. Matsunaga, K. Akasu, 2006, Internal medicine.

Detection of a point mutation in cholesteryl ester transfer protein gene by polymerase chain reaction-mediated site-directed mutagenesis.

J. Sasaki, K. Arakawa, A. Matsunaga, 1993, Biochimica et biophysica acta.

An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population

J. Sasaki, J. Breslow, A. Matsunaga, 1995, Human Genetics.

Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia.

J. Sasaki, K. Arakawa, A. Matsunaga, 1992, Atherosclerosis.

Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome.

J. Sasaki, K. Yokote, J. Kobayashi, 2000, Clinica chimica acta; international journal of clinical chemistry.

Apolipoprotein A-I Mutations and Clinical Evaluation

A. Matsunaga, 2014 .

Apolipoprotein A-I Mutations

Y. Uehara, K. Saku, B. Zhang, 2010 .

A comparative crossover study of the effects of fluvastatin and pravastatin (FP-COS) on circulating autoantibodies to oxidized LDL in patients with hypercholesterolemia.

K. Saku, K. Kumagai, A. Matsunaga, 2005, Journal of atherosclerosis and thrombosis.

Effects of Monatepil, a Novel Calcium Antagonist with α1-Adrenergic Blocking Activity, on the Low-Density Lipoprotein Receptor in Human Skin Fibroblasts

J. Sasaki, K. Arakawa, A. Matsunaga, 1997, Cardiovascular Drugs and Therapy.

Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs.

J. Sasaki, K. Arakawa, A. Matsunaga, 1991, Atherosclerosis.

Serum glycoproteins and severity of coronary atherosclerosis.

J. Sasaki, S. Kono, K. Arakawa, 1995, American heart journal.

A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.

J. Sasaki, K. Arakawa, S. Horiuchi, 1999, Arteriosclerosis, thrombosis, and vascular biology.

[Familial HDL deficiency].

A. Matsunaga, Hiroaki Arishima, 2007, Nihon rinsho. Japanese journal of clinical medicine.

Genetic analysis of Brugada syndrome in Western Japan: two novel mutations.

K. Saku, H. Noguchi, K. Kumagai, 2004, Circulation journal : official journal of the Japanese Circulation Society.

Evaluation of the change of flow change on opening mouth after superficial temporal artery-middle cerebral artery bypass

H. Abe, Tooru Inoue, K. Fukuda, 2015 .

Different coagulability and fibrinolytic activity during exercise depending on exercise intensities.

J. Sasaki, K. Arakawa, A. Kiyonaga, 1992, Thrombosis research.

Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects

Hiroaki Tanaka, J. Sasaki, K. Arakawa, 1992, Cardiovascular Drugs and Therapy.

Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys)

K. Masutani, K. Miyake, H. Nakashima, 2018, CEN Case Reports.

A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease.

J. Sasaki, S. Mochizuki, A. Endo, 2004, Atherosclerosis.

Plasmin and thrombin inhibitors in essentially untreated patients with coronary artery spasm.

J. Sasaki, K. Arakawa, A. Matsunaga, 1993, International journal of cardiology.

Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy.

J. Miyazaki, K. Arakawa, H. Urata, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

Effects of captopril on opioid peptides during exercise and quality of life in normal subjects.

J. Sasaki, K. Arakawa, A. Kiyonaga, 1991, American heart journal.

SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome.

H. Morita, K. Saku, T. Tada, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Fluorescence in situ hybridization（FISH）の末梢血塗抹標本への応用

I. Miura, A. Matsunaga, Y. Takamatsu, 2011 .

Familial hypobetalipoproteinemia associated with hypothyroidism.

J. Sasaki, K. Arakawa, A. Matsunaga, 1995, Internal medicine.

Administration of slow-release nifedipine does not affect lactate threshold, hormone release during exercise, and quality of life in normal subjects

Hiroaki Tanaka, J. Sasaki, K. Arakawa, 1992, Cardiovascular Drugs and Therapy.

A rare case of acute myocardial infarction with a non-specific symptom in a young female with systemic lupus erythematosus.

S. Miura, K. Saku, A. Matsunaga, 2017, Journal of cardiology cases.

SCN 5 A Mutation Is Associated With Early and Frequent Recurrence of Ventricular Fibrillation in Patients With Brugada Syndrome

H. Morita, K. Saku, T. Tada, 2010 .

Evaluation before and after treatment of dural arteriovenous fistulas by carotid ultrasonography

Tooru Inoue, Hirofumi Shimada, T. Ogata, 2017 .

Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.

D. Sviridov, J. Sasaki, N. Fidge, 2001, Atherosclerosis.

Identification of two apolipoprotein variants, A‐I Karatsu (Tyr 100 → His) and A‐I Kurume (His 162 → Gin)

J. Sasaki, K. Arakawa, A. Matsunaga, 1996, Clinical genetics.

Identification of two apolipoprotein variants, A-I Kaho (Asp 51-->Val) and A-I Lys 107 deletion.

J. Sasaki, K. Arakawa, A. Matsunaga, 1996, Journal of atherosclerosis and thrombosis.

A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I

A. Matsunaga, K. Joh, S. Takasaki, 2018, CEN Case Reports.

The usefulness of carotid ultrasonography in identifying direct-type carotid cavernous fistula

Tooru Inoue, K. Fukuda, Hirofumi Shimada, 2015 .

Statins Induce the Gene Expression of Apolipoprotein A5 in HepG2 Cells

B. Zhang, Y. Uehara, K. Saku, 2011 .

Topics in lipoprotein glomerulopathy: an overview

H. Nakashima, A. Matsunaga, Kenji Ito, 2014, Clinical and Experimental Nephrology.

Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers.

J. Sasaki, K. Arakawa, A. Matsunaga, 1990, Clinical therapeutics.

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

S. Miura, S. Imaizumi, K. Saku, 2018, Heart and Vessels.

Clinical application of the different cross-reactivities of anti-insulin antibodies to insulin lispro to evaluate endogenous insulin secretion.

Y. Akehi, K. Ohkubo, A. Matsunaga, 2013, Clinica chimica acta; international journal of clinical chemistry.

Reactivity of direct assays for low-density lipoprotein (LDL) cholesterol toward charge-modified LDL in hypercholesterolemia.

M. Kuroki, S. Miura, S. Imaizumi, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: the SPECIAL Study.

T. Imaizumi, K. Saku, K. Yoshinaga, 2008, Atherosclerosis.

Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis.

K. Rye, K. Saku, R. Katafuchi, 2006, Clinica chimica acta; international journal of clinical chemistry.

Association between fast-migrating low-density lipoprotein subfraction as characterized by capillary isotachophoresis and intima-media thickness of carotid artery.

J. Hayashi, K. Saku, K. Kumagai, 2006, Atherosclerosis.

Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration.

Y. Uehara, K. Saku, H. Itabe, 2006, Atherosclerosis.

Potent capillary isotachophoresis (cITP) for analyzing a marker of coronary heart disease risk and electronegative low-density lipoprotein (LDL) in small dense LDL fraction.

Y. Uehara, K. Saku, A. Matsunaga, 2005, Circulation journal : official journal of the Japanese Circulation Society.

[Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012].

S. Ichiyama, F. Nomura, A. Nakayama, 2014, The Japanese journal of antibiotics.

A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration

T. Yanase, A. Maeyama, K. Ohkubo, 2014, Meta gene.

The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure

S. Miura, S. Imaizumi, K. Saku, 2017, Journal of clinical medicine research.

Vancomycin Bactericidal Activity as a Predictor of 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia

H. Ishikura, A. Matsunaga, B. Tsuji, 2011, Antimicrobial Agents and Chemotherapy.

Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection

T. Ishikawa, H. Ishikura, A. Matsunaga, 2013, Scandinavian journal of infectious diseases.

Therapeutic approaches to the regulation of metabolism of high-density lipoprotein. Novel HDL-directed pharmacological intervention and exercise.

M. Kuroki, Y. Uehara, K. Saku, 2013, Circulation journal : official journal of the Japanese Circulation Society.

A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate

T. Miyata, S. Sugiyama, A. Matsunaga, 2017, Case Reports in Nephrology and Dialysis.

Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344-->Ser).

T. Yanase, J. Sasaki, E. Maeda, 1995, Journal of lipid research.

A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.

Wei Huang, J. Sasaki, K. Arakawa, 2000, Arteriosclerosis, thrombosis, and vascular biology.

A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.

J. Sasaki, K. Arakawa, A. Matsunaga, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.

Y. Uehara, K. Saku, A. Matsunaga, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects.

Hiroaki Tanaka, J. Sasaki, M. Shindo, 1999, Metabolism: clinical and experimental.

A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy.

H. Sugiyama, Y. Maeshima, H. Makino, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A rare cause of posttransplantation nephrotic syndrome.

V. D’Agati, K. Foster, M. Stokes, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2

A. Shimizu, M. Fukunaga, K. Nagahama, 2018, Case Reports in Nephrology and Dialysis.

Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis.

A. Matsunaga, Takao Saito, 2014, Kidney international.

Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy

A. Matsunaga, K. Joh, S. Takasaki, 2015, Case Reports in Nephrology and Dialysis.

[I. Metabolic disease: 4. Lipid metabolism abnormalities].

A. Matsunaga, Kenji Ito, Takao Saito, 2011, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia

A. Matsunaga, Takao Saito, 2014, Clinical and Experimental Nephrology.

KIDNEY BIOPSY TEACHING CASE A Rare Cause of Posttransplantation Nephrotic Syndrome

K. Foster, M. Stokes, A. Matsunaga, 2005 .

Development of risk factor-based scoring system for detection of hypervirulent Klebsiella pneumoniae bloodstream infections

A. Togawa, A. Matsunaga, Y. Takamatsu, 2020, Gut Pathogens.

Apolipoprotein E ε4

S. Sakoda, J. Sasaki, M. Osame, 1994, Neurology.

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2017, BMC Cancer.

"Association of apolipoprotein E allele !e4 with late-onset familial and sporadic Alzheimer's disease": Comment.

A. Matsunaga, J. Sasaki, S. Sakoda, 1994 .

Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients.

S. Miura, K. Saku, K. Kumagai, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Structural and functional properties of apolipoprotein A-I mutants.

J. Sasaki, A. Matsunaga, T. Koga, 2000, Journal of atherosclerosis and thrombosis.

[Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009].

S. Ichiyama, F. Nomura, M. Yasujima, 2011, The Japanese journal of antibiotics.

Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108-->Arg) and A-I Hita (Ala-95-->Asp).

J. Sasaki, K. Arakawa, A. Matsunaga, 1994, Biochimica et biophysica acta.

A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes

A. Matsunaga, E. Muso, H. Yokoyama, 2019, CEN Case Reports.

A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka

A. Matsunaga, E. Muso, Takao Saito, 2018, Clinical nephrology. Case studies.

Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.

K. Takakura, M. Kuroki, H. Higuchi, 1987, Japanese journal of cancer research : Gann.

A Continuous Murmur as the Only Clinical Sign for Complex Coronary Artery Fistulas Diagnosis

S. Miura, A. Matsunaga, M. Sugihara, 2021, JACC. Case reports.

A Giant Left Ventricular Thrombus in a Patient with Acute Myocardial Infarction

K. Saku, A. Matsunaga, Y. Tsuchiya, 2001, Angiology.